Prestige Consumer Healthcare Inc. (NYSE:PBH) is a top choice among cheap healthcare stocks to buy heading into 2026, with analysts bullish on the stock and a 32% upside potential. Susan Anderson from Canaccord trimmed the price target to $88 from $100 but maintained a ‘Buy’ rating, citing solid results and Clear Eyes supply timing.

In the second-quarter results, Prestige Consumer Healthcare Inc. (NYSE:PBH) saw a 6.1% decrease in North American segment revenues, offset by a 2.5% increase in international segment revenues. The company remains focused on product innovation and e-commerce strategies, as revealed in the earnings call.

Prestige Consumer Healthcare Inc. (NYSE:PBH) is a New York-based provider of over-the-counter (OTC) health and personal care products, operating through North American and International OTC Healthcare segments. Established in 1996, the company continues to deliver essential products to consumers worldwide.

Read more at Yahoo Finance: Here’s Why Analysts Are Positive On Prestige Consumer Healthcare Inc. (PBH)